National Heart, Lung, and Blood Institute; Notice of Closed Meeting, 37460 [2020-13319]
Download as PDF
<![CDATA[
37460
Federal Register / Vol. 85, No. 120 / Monday, June 22, 2020 / Notices
Rockville, MD 20857, Phone: (215) 861–
4385, or Email: MFountain@hrsa.gov.
SUPPLEMENTARY INFORMATION:
Intended Recipient of Award:
Education Development Center, Inc.
Amount of Non-Competitive Award:
Approximately $330,000/year for FY
2020, FY 2021, and FY 2022.
Budget Period: 09/01/2019–08/31/
2020; 09/01/2020–08/31/2021; 09/01/
2021–08/31/2022.
CFDA Number: 93.110.
Authority: Social Security Act, Title V,
§ 511 (42 U.S.C. 711).
Justification: The MIECHV Program,
an evidence-based home visiting
program, seeks to improve maternal and
child health outcomes and address
various social determinants that impact
health equity such as reducing child
abuse and neglect, addressing family
violence, promoting child development
and school readiness, and improving
family economic self-sufficiency for
families considered most at-risk. In
support of HRSA’s FY 2019–FY 2022
Strategic Goals focused on health
equity, the MIECHV Program proposes
to develop a home visiting specific
health equity framework utilizing
quality improvement as a methodology.
The HVCoIIN 2.0 is designed to
facilitate the delivery and accelerate the
improvement of home visiting services
provided by MIECHV Program
recipients, including subrecipient local
implementing agencies (LIAs) utilizing
continuous quality improvement
methodologies. The CoIIN provides a
platform and strategy for collaborative
learning and quality improvement
toward common measurable aims—
rapid-cycle tests of change ideas.
The HVCoIIN has three main priority
areas. Priority Area #2 is focused on
‘‘testing of new change ideas.’’ This
priority area is designed to develop and
subsequently refine discrete sets of
change ideas based on evidence in the
field and relevance to home visiting
implementation. The grantee will carry
out all the activities pertaining to the
development of the health equity
framework. Proposed activities will
include:
• Identify a health equity framework
and adapt for MIECHV;
• Develop theory of change, (how and
why the desired change is expected to
happen); key driver diagrams, (the
Grantee/organization name
Grant No.
Education Development Center, Inc .....................................
UF4MC26525
Thomas J. Engels,
Administrator.
[FR Doc. 2020–13338 Filed 6–19–20; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Sep<11>2014
18:08 Jun 19, 2020
Jkt 250001
State
FY 2020 funding
FY 2021 funding
FY 2022 funding
$328,797
$329,980
$324,637
MA
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Mentored Patient-Oriented Research Review
Committee.
Date: July 23–24, 2020.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health (NIH),
One Rockledge Center, 6705 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Stephanie Johnson Webb,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung, and Blood Institute, National Institutes
of Health, 6705 Rockledge Drive, Room 208–
V, Bethesda, MD 20892, (301) 827–7992,
stephanie.webb@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: June 16, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–13319 Filed 6–19–20; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
relationship between the overall aim of
the project, the drivers that contribute
directly to the aim) change ideas,
measures and proposed tests of change;
• Implement a quality improvement
strategy such as: Breakthrough Series,
Plan-Do-Study-Act Cycles, to test and
eventually demonstrate improvements
in program outcomes through a health
equity collaborative; and pilot test with
MIECHV awardees over 12–18 months;
• Apply the health equity framework
that demonstrated improvements to
twelve current HV CoIIN 2.0 scale topics
(developmental screening,
breastfeeding, and maternal depression)
and new topic CoIINs (intimate partner
violence and well child care); and
• Create a final health equity CoIIN
playbook with measures, refined tests of
change that can be used to spread
lessons learned across home visiting
programs. EDC was awarded a 5-year
HV CoIIN cooperative agreement on
September 1, 2017. They have
successfully led the first national effort
utilizing CQI methods to assist awardees
in improving MIECHV Program
implementation, performance measures
and evidence based maternal and child
health outcomes.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; ‘‘Emergency Awards: Rapid
Investigation of Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS–CoV–2) and
Coronavirus Disease 2019 (COVID–19).’’
E:\FR\FM\22JNN1.SGM
22JNN1
]]>Agencies
[Federal Register Volume 85, Number 120 (Monday, June 22, 2020)]
[Notices]
[Page 37460]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-13319]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Heart, Lung, and Blood Initial Review Group;
NHLBI Mentored Patient-Oriented Research Review Committee.
Date: July 23-24, 2020.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Health (NIH), One Rockledge Center,
6705 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Stephanie Johnson Webb, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 208-V, Bethesda, MD 20892, (301) 827-7992,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: June 16, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-13319 Filed 6-19-20; 8:45 am]
BILLING CODE 4140-01-P
